Details of the Drug

General Information of Drug (ID: DM4LYFJ)

• Drug Name: Hepatitis C immune globulin

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis C virus infection	1E51.1	Phase 3	[1]

• Cross-matching ID: TTD ID: D01VSR

References

• [1] Clinical pipeline report, company report or official report of Biotest Pharmaceuticals.